This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 810495
Submitted by lobbyist on: July 24, 2018 08:59:04 AM
Accepted by Registrar on: July 24, 2018 09:34:03 AM
Designated Filer Information
| Robidoux, Michel |
| 110 rue de Lauzon | |
|
Boucherville, QC, J4B 1E6
|
450-641-4903 |
| Canada |
Organization Information
| Sandoz Canada |
| Sandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to discover new ways to improve and extend people's lives. For further information please visit www.sandoz.ca |
| 110 rue de Lauzon | |
|
Boucherville, BC, J4B 1E6
|
450-641-4903 |
| Canada |
Relevant Affiliates
Type:
| Business Name | Mailing Address | Contact Information |
|---|---|---|
| Sandoz Canada |
110 rue de Lauzon
Boucherville, QC J4B 1E6 Canada |
Phone: 450-641-4903 |
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
| July 24, 2018 | |
| January 24, 2019 |
Organization's In-House Lobbyists
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Raising awareness of government officials of generic products development by Sandoz Canada and the potential savings realized by the healthcare system. Increase utilization rates for generics Raise awareness of digital treatment solutions to treat patients with addictions
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | July 24, 2018 | |
| Public Agency | Mental Health and Addictions | January 11, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Development, establishment, amendment or termination of any program, policy or decision
Introduction, modification or repeal of legislation, a bill or regulation
Discuss matters to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc. Raising awareness of government officials of generic and biosimilars products development by Sandoz Canada and the potential savings realized by the healthcare system. Improve regulatory environment and utilization rates for generics and biosimilars. Improve regulatory environment to allow pharmacies in British Columbia to sell and distribute medical cannabis to patients . Raise awareness of digital treatment solutions to treat patients with addictions.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Minister | Dix, Adrian | Minister of Health | July 24, 2018 |
| Minister | Horgan, John | Premier | July 24, 2018 |
| MLA | Bernier, Mike | Peace River South | July 24, 2018 |
| MLA | Cadieux, Stephanie | Surrey South | July 24, 2018 |
| MLA | Darcy, Judy | New Westminster | July 24, 2018 |
| Public Agency | Health | July 24, 2018 | |
| Public Agency | Mental Health and Addictions | January 11, 2019 | |
| Public Agency | The University of British Columbia | July 24, 2018 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Raising awareness of government officials of biosimilars products development by Sandoz Canada and the potential savings realized by the healthcare system. Increase utilization rates for biosimilars
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | July 24, 2018 |